New: The Intelligence Brief — Premium weekly S&P 500 analysis Learn more

Scanning data sources...

S&P 500 intelligence from 25+ data sources, analyzed and delivered to your inbox.

Free Newsletters

The Daily FilingDaily
The Capitol DeskMon
The Regulatory PulseWed
The Signal BoardFri
The Deep DiveMonthly

Subscribe to all →

Premium

Intelligence Brief
Pricing
Subscriber Login

Company

About
All Issues
Stories
Contact

Privacy Terms

Get S&P 500 intelligence in your inbox. Free daily newsletter.

Biogen (BIIB) | The Filing Cabinet

Stories
Biogen

Biogen

BIIB

Health CareBiotechnology

SEC EDGAR

1story

1signal

1category

Coverage by Category

Corporate Events1 story

Signal Timeline

Most recent first

Material Event•Medium

Biogen Chief Legal Officer Susan Alexander to depart end of May 2026

Biogen's Chief Legal Officer departs after navigating the Aduhelm approval controversy and subsequent Medicare coverage restrictions — a tenure defined by regulatory and reimbursement battles that reshaped the company's Alzheimer's strategy. The <strong>end-of-May exit</strong> gives the incoming CLO a buffer before mid-year data readouts on the lecanemab label expansion.

Mar 11, 2026

All Stories

1 story

Biogen Chief Legal Officer Susan Alexander to depart end of May 2026

Susan H. Alexander, Chief Legal Officer of Biogen, will depart the company at the end of May 2026. The company has initiated a search for her replacement.

Biogen·18h ago·1 min read

Biogen

Coverage by Category

Signal Timeline

All Stories

Biogen Chief Legal Officer Susan Alexander to depart end of May 2026

More in Health Care

Get Biogen updates in your inbox